Immune Effector Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Immune Effector Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 1

NCT07424222

Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)

This is a pilot study to gather information about safety and efficacy of using ruxolitinib (RUX) to treat Immune Effector Cell Associated Hemophagocytic Lymphoh…

Location not specified16 participantsStarted 2026-06-01

Treatment: Ruxolitinib